RESUMO
Many recombinant therapeutic proteins are purified from Escherichia coli. While expression in E. coli is easily achieved, some disadvantages such as protein aggregation, formation of inclusion bodies, and contamination of purified proteins with the lipopolysaccharides arise. Lipopolysaccharides have to be removed to prevent inflammatory responses in patients. Use of the Gram-positive Bacillus anthracis as an expression host offers a solution to circumvent these problems. Using the multiple protease-deficient strain BH460, we expressed a fusion of the N-terminal 254 amino acids of anthrax lethal factor (LFn), the N-terminal 389 amino acids of diphtheria toxin (DT389) and human transforming growth factor alpha (TGFα). The resulting fusion protein was constitutively expressed and successfully secreted by B. anthracis into the culture supernatant. Purification was achieved by anion exchange chromatography and proteolytic cleavage removed LFn from the desired fusion protein (DT389 fused to TGFα). The fusion protein showed the intended specific cytotoxicity to epidermal growth factor receptor-expressing human head and neck cancer cells. Final analyses showed low levels of lipopolysaccharides, originating most likely from contamination during the purification process. Thus, the fusion to LFn for protein secretion and expression in B. anthracis BH460 provides an elegant tool to obtain high levels of lipopolysaccharide-free recombinant protein.
Assuntos
Antígenos de Bactérias/isolamento & purificação , Bacillus anthracis/metabolismo , Toxinas Bacterianas/isolamento & purificação , Toxina Diftérica/isolamento & purificação , Imunotoxinas/isolamento & purificação , Proteínas Recombinantes de Fusão/isolamento & purificação , Fator de Crescimento Transformador alfa/isolamento & purificação , Antígenos de Bactérias/biossíntese , Antígenos de Bactérias/farmacologia , Bacillus anthracis/genética , Toxinas Bacterianas/biossíntese , Toxinas Bacterianas/farmacologia , Linhagem Celular Tumoral , Cromatografia por Troca Iônica , Toxina Diftérica/biossíntese , Toxina Diftérica/farmacologia , Humanos , Imunotoxinas/farmacologia , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/farmacologia , Fator de Crescimento Transformador alfa/biossíntese , Fator de Crescimento Transformador alfa/farmacologiaRESUMO
Cornichon proteins are structurally related transmembrane proteins that have been studied in and Drosophila and yeast. In Drosophila, Cornichon (Cni) is involved in embryo polarization by the TGFalpha-related Gurken. In yeast, the Cni-related Erv14 is required for axial budding. A cargo receptor function has been proposed for Erv14 and Cni. Four mammalian Cni-like sequences have been identified. We carried out parallel functional analyses of the human Cni ortholog CNIH and Drosophila Cni in the processing and presentation of TGFalpha family proteins. Human CNIH complements the loss of Erv14 in yeast. Human CNIH and Drosophila Cni are primarily localized in the endoplasmic reticulum and associate with immature TGFalpha family proteins. Alterations of cornichon expression result in changes in transport, processing and secretion of TGFalpha proteins. In particular, increased cornichon expression retains TGFalpha proteins in the endoplasmic reticulum, whereas cornichon is required for their transport and secretion. Thus, cornichon proteins represent a functionally conserved protein family that acts in the selective transport and maturation of TGFalpha family proteins.
Assuntos
Células CHO/metabolismo , Proteínas de Drosophila/metabolismo , Proteínas do Ovo/metabolismo , Proteínas de Membrana/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Fator de Crescimento Transformador alfa/metabolismo , Sequência de Aminoácidos , Animais , Células CHO/citologia , Cricetinae , Cricetulus , Drosophila , Proteínas de Drosophila/química , Proteínas de Drosophila/isolamento & purificação , Proteínas do Ovo/química , Proteínas do Ovo/isolamento & purificação , Humanos , Proteínas de Membrana/química , Proteínas de Membrana/isolamento & purificação , Dados de Sequência Molecular , Transporte Proteico , RNA Interferente Pequeno , Saccharomyces cerevisiae , Proteínas de Saccharomyces cerevisiae/química , Proteínas de Saccharomyces cerevisiae/isolamento & purificação , Fator de Crescimento Transformador alfa/isolamento & purificaçãoRESUMO
Transforming growth factor-alpha (TGF-alpha) is overexpressed in colonic carcinomas and promotes mucosal wound healing. It may be implicated in chronic inflammatory bowel disease (IBD). We analyzed the expression of TGF-alpha and its receptor, epidermal growth factor receptor (EGF-r), in the colonic mucosa of patients with Crohn's disease (CD) or ulcerative colitis (UC), in active or inactive stages, as compared with controls. Proteins and mRNA were detected in biopsies from the right and left colon and in surgical colonic specimens. Immunoblot analysis revealed TGF-alpha protein as a 29 kDa band. This band was normally expressed in uninvolved colonic mucosa of patients with CD or UC whether in active or inactive stages, but decreased or absent in involved mucosa of active IBD, even when TGF-alpha mRNA and EGF-r protein were detected. In the unaffected mucosa of CD, the intensity of TGF-alpha immunoreactivity was similar to that of controls in the right colon but stronger (P = 0.05) in the left colon. There was no TGF-alpha overexpression in dysplastic regions. In conclusion, in active IBD disease, the decreased TGF-alpha protein amount seems not only related to epithelial cell loss but reflects a down-regulation at least at the protein level. We speculate that TGF-alpha does not play a role within the active stage but may be implicated later in the repair process.
Assuntos
Colo/química , Receptores ErbB/isolamento & purificação , Doenças Inflamatórias Intestinais/etiologia , Mucosa Intestinal/química , Fator de Crescimento Transformador alfa/isolamento & purificação , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia , Western Blotting , Colite Ulcerativa/etiologia , Colonoscopia , Doença de Crohn/etiologia , Feminino , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Distribuição TecidualRESUMO
Transforming growth factor alpha (TGF-alpha), epidermal growth factor (EGF), and related factors mediate their biological effects by binding to the extracellular domain of the EGF receptor, which leads to activation of the receptor's cytoplasmic tyrosine kinase activity. Much remains to be determined, however, about the detailed molecular mechanism involved in this ligand-induced receptor activation. The determination of the binding mechanism and the related thermodynamic and kinetic parameters are of prime importance. To do so, we have used a surface plasmon resonance-based biosensor (the BIAcore) that allows the real-time recording of the interaction between TGF-alpha and the extracellular domain of the EGF receptor. By immobilizing different biotinylated derivatives of TGF-alpha on the sensor chip surface, we demonstrated that the N-terminus of TGF-alpha is not directly involved in receptor binding. By optimizing experimental conditions and interpreting the biosensor results by several data analysis methods, we were able to show that the data do not fit a simple binding model. Through global analysis of the data using a numerical integration method, we tested several binding mechanisms for the TGF-alpha/EGF receptor interaction and found that a conformational change model best fits the biosensor data. Our results, combined with other analyses, strongly support a receptor activation mechanism in which ligand binding results in a conformation-driven exposure of a dimerization site on the receptor.
Assuntos
Receptores ErbB/química , Receptores ErbB/metabolismo , Espaço Extracelular/química , Espaço Extracelular/metabolismo , Fator de Crescimento Transformador alfa/química , Fator de Crescimento Transformador alfa/metabolismo , Ligação Competitiva , Biotinilação/métodos , Simulação por Computador , Humanos , Radioisótopos do Iodo/metabolismo , Cinética , Modelos Químicos , Conformação Proteica , Estrutura Terciária de Proteína , Estreptavidina/química , Estreptavidina/metabolismo , Ressonância de Plasmônio de Superfície , Termodinâmica , Fator de Crescimento Transformador alfa/isolamento & purificaçãoRESUMO
Transforming growth factor alpha (TGF-alpha) is biosynthesized as a membrane-bound precursor protein, pro-TGF-alpha, that undergoes sequential endoproteolytic cleavages to release a soluble form of the factor. In the present study, we have analyzed the biosynthesis and regulation of TGF-alpha production in human tumor-derived cell lines that endogenously express pro-TGF-alpha and the epidermal growth factor (EGF) receptor. These cells biosynthesized membrane-anchored forms of the TGF-alpha that accumulated on the cell surface. Membrane-bound pro-TGF-alpha interacted with the EGF receptor, and complexes of receptor and pro-TGF-alpha contained tyrosine-phosphorylated receptor. Activation of the EGF receptor by soluble EGF or TGF-alpha had a dual effect on TGF-alpha production: an increase in pro-TGF-alpha mRNA levels and an increase in pro-TGF-alpha cleavage. These effects were largely prevented by preincubation with an anti-EGF receptor monoclonal antibody that blocked ligand binding. Growth factor autoinduction of cleavage could be stimulated by several second messenger pathways that are activated by the EGF receptor, including protein kinase C and intracellular calcium, and by other alternative mechanisms. EGF-stimulated cleavage of pro-TGF-alpha could be partially blocked by inhibition of these second messenger pathways. These results suggest that juxtacrine stimulation takes place in human tumor cells that coexpress both the EGF receptor and membrane-anchored TGF-alpha and that TGF-alpha is able to induce its own endoproteolytic cleavage by activating the EGF receptor.
Assuntos
Precursores de Proteínas/metabolismo , Processamento de Proteína Pós-Traducional , Fator de Crescimento Transformador alfa/biossíntese , Fator de Crescimento Transformador alfa/metabolismo , Animais , Anticorpos/farmacologia , Autorradiografia , Células CHO , Calcimicina/farmacologia , Carcinoma de Células Escamosas , Membrana Celular/metabolismo , Cricetinae , Cisteína/metabolismo , Receptores ErbB/metabolismo , Feminino , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Masculino , Processamento de Proteína Pós-Traducional/efeitos dos fármacos , Ratos , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/metabolismo , Radioisótopos de Enxofre , Acetato de Tetradecanoilforbol/farmacologia , Transfecção , Fator de Crescimento Transformador alfa/isolamento & purificação , Células Tumorais CultivadasRESUMO
A secretory production system for the active form of transforming growth factor alpha (TGF alpha) was established in Streptomyces lividans using a gene encoding the secretory protease inhibitor, Streptomyces subtilisin inhibitor (SSI). It was demonstrated that deletion of one of the putative dual ssi terminators is effective to extracellularly produce a heterologous polypeptide in a fused form. The recombinant fusion protein, SSI::TGF alpha, was purified to homogeneity by a combination of hydrophobic chromatography and reverse-phase high-performance liquid chromatography (RP-HPLC). It was noteworthy that the SSI::TGF alpha hybrid protein exhibited bifunctional activity: the TGF alpha activity for cell growth promotion and the inhibitory activity of SSI. Taken together with the results of analytical gel filtration, these findings strongly indicate that each moiety in the fusion protein correctly folds and the whole hybrid molecule exists in a dimeric form, which results in its bifunctional activity.
Assuntos
Fator de Crescimento Transformador alfa/metabolismo , Fator de Crescimento Transformador alfa/farmacologia , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Divisão Celular/efeitos dos fármacos , Códon de Terminação , Relação Dose-Resposta a Droga , Vetores Genéticos/genética , Humanos , Proteínas Recombinantes de Fusão/isolamento & purificação , Proteínas Recombinantes de Fusão/metabolismo , Proteínas Recombinantes de Fusão/farmacologia , Inibidores de Serina Proteinase/genética , Inibidores de Serina Proteinase/metabolismo , Streptomyces/genética , Subtilisinas/antagonistas & inibidores , Fator de Crescimento Transformador alfa/genética , Fator de Crescimento Transformador alfa/isolamento & purificaçãoRESUMO
OBJECTIVE: To characterize the putative seminal growth promoting factor serendipitously observed when human seminal plasma was analyzed for bioactive FSH. DESIGN: A pool of human seminal plasma was subjected to sequential Sephadex G-75 (superfine) chromatography and high-performance size exclusion liquid chromatography. The fractions were tested for mitogenic activity using a rat granulosa cell assay and normal rat kidney (NRK) cells. Properties of the factor were established and characterization by gel electrophoresis and neutralization with antibody were accomplished. SETTING: Reproductive Biology Research Laboratory at McMaster University Medical Centre. MAIN OUTCOME MEASURES: Ability of purified fractions of human seminal plasma to augment the uptake of tritiated thymidine into cell DNA. RESULTS: Mitogenic activity of human seminal plasma was augmented in the presence of FSH but not hCG, PRL, E2, T, P, or dihydrotestosterone. The putative growth factor synergized with insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), and transforming growth factor beta (TGF-beta) but not with TGF-alpha. Mitogenic activity was neutralized by a specific TGF-alpha antibody in a dose-dependent manner. The molecular weight of the factor as assessed by gel electrophoresis is 6 kd. CONCLUSIONS: Human seminal plasma contains a mitogen that is similar to TGF-alpha.
Assuntos
Sêmen/química , Fator de Crescimento Transformador alfa/isolamento & purificação , Animais , Divisão Celular/efeitos dos fármacos , Divisão Celular/fisiologia , Cromatografia em Gel , Cromatografia Líquida de Alta Pressão , Eletroforese em Gel de Poliacrilamida , Feminino , Células da Granulosa/citologia , Substâncias de Crescimento/farmacologia , Humanos , Masculino , Ratos , Ratos Sprague-Dawley , Fator de Crescimento Transformador alfa/farmacologia , Fator de Crescimento Transformador alfa/fisiologiaRESUMO
We have demonstrated previously that the synthetic glucocorticoid dexamethasone suppresses the growth of Con8 rat mammary tumor cells, which are derived from the 13762NF transplantable, hormone-responsive rat mammary adenocarcinoma. Dexamethasone inhibited [3H]thymidine incorporation into Con8 cells at high cell density under both serum and serum-free conditions. Fractionation in nonreducing sodium dodecyl sulfate-polyacrylamide gels of proteins secreted from dexamethasone-treated and untreated Con8 mammary tumor cells revealed two size classes of glucocorticoid inhibited mitogenic activities; a larger M(r) 27,000-33,000 and a smaller M(r) 5,000-12,000 activity. Both size classes of mitogens restimulated the growth of glucocorticoid-suppressed Con8 cells suggesting that they can act in an autocrine fashion. The smaller mitogen was identified as transforming growth factor alpha (TGF-alpha) since this activity competed with 125I-epidermal growth factor (EGF) for EGF receptor binding and was selectively immunodepleted with monoclonal TGF-alpha antibodies but not with EGF antibodies. Western blots and radioreceptor assay of Con8-secreted proteins revealed that glucocorticoids inhibited the production of a M(r) 5500 immunoreactive TGF-alpha protein by 10-fold. Consistent with a steroid effect on the level of TGF-alpha production, rather than on its activity, the specific mitogenic activities of the TGF-alpha s secreted by dexamethasone-treated and untreated Con8 cells were identical to that of recombinant human TGF-alpha. Treatment of intact cells with suramin, which dissociates ligand-receptor complexes, revealed that the EGF receptor-mediated mitogenic response is functional in both glucocorticoid-treated and untreated cells. Taken together, our results demonstrate that glucocorticoids suppress Con8 mammary tumor cell growth and disrupt a potential TGF-alpha autocrine loop which results in a dramatic reduction in the level of extracellular TGF-alpha.
Assuntos
Adenocarcinoma/patologia , Dexametasona/farmacologia , Neoplasias Mamárias Experimentais/patologia , Fator de Crescimento Transformador alfa/antagonistas & inibidores , Células 3T3 , Adenocarcinoma/metabolismo , Animais , Divisão Celular/efeitos dos fármacos , Meios de Cultura Livres de Soro , DNA/biossíntese , Receptores ErbB/metabolismo , Feminino , Neoplasias Mamárias Experimentais/metabolismo , Camundongos , Mitógenos/antagonistas & inibidores , Mitógenos/isolamento & purificação , Peso Molecular , Transplante de Neoplasias , Ratos , Ratos Endogâmicos F344 , Fator de Crescimento Transformador alfa/isolamento & purificação , Fator de Crescimento Transformador alfa/metabolismo , Células Tumorais CultivadasRESUMO
We have purified and characterized a novel 30-kDa glycoprotein (gp30) with TGF alpha-like properties secreted from the estrogen receptor negative breast cancer cell line MDA-MB-231. This factor was immunoprecipitated by an anti-TGF alpha polyclonal antibody and also had TGF alpha-like biological activity, as assayed by EGF radioreceptor assay and anchorage-independent assays. In addition, the novel growth factor stimulated phosphorylation of the EGF receptor and erbB-2 receptor. However, the novel growth factor, unlike EGF and TGF alpha, bound to heparin-Sepharose. Purification of gp30 was obtained to apparent homogeneity by heparin affinity chromatography and subsequent reversed-phase chromatography. Tunicamycin treatment in vivo or N-glycanase deglycosylation in vitro revealed a putative precursor of approximately 22 kDa molecular mass in contrast to the "normal" 16-kDa precursor species for TGF alpha. In vitro translation of total mRNA from MDA-MB-231 cells confirmed the size of the putative precursor. Biochemical characterization of gp30 was begun by V8 protease digestion of the deglycosylated polypeptide and the translated products. Peptide mapping of V8-digested, immunoprecipitated material suggests that the amino acid sequence of this unique protein is distinct from mature TGF alpha and not the result of a posttranslational modification of the precursor. We conclude that this TGF alpha-like (gp30) polypeptide is a novel growth factor with agonistic activity for both EGF and erbB-2 receptors.
Assuntos
Receptores ErbB/metabolismo , Glicoproteínas/isolamento & purificação , Substâncias de Crescimento/isolamento & purificação , Fator de Crescimento Transformador alfa/isolamento & purificação , Animais , Anticorpos , Anticorpos Monoclonais , Neoplasias da Mama , Adesão Celular , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Cromatografia de Afinidade , Cromatografia em Gel , Ensaio de Imunoadsorção Enzimática , Fator de Crescimento Epidérmico/metabolismo , Receptores ErbB/efeitos dos fármacos , Feminino , Glicoproteínas/farmacologia , Substâncias de Crescimento/farmacologia , Humanos , Cinética , Peso Molecular , Mapeamento de Peptídeos , Fosforilação , Biossíntese de Proteínas , Proteínas Tirosina Quinases/metabolismo , Radioimunoensaio , Ensaio Radioligante , Receptores de Estrogênio/análise , Fator de Crescimento Transformador alfa/farmacologia , Tunicamicina/farmacologiaRESUMO
Transforming growth factor alpha (TGF alpha) is a mitogenic polypeptide that is structurally homologous to epidermal growth factor (EGF) and appears to bind to the same receptor in all systems tested previously. In the present study, TGF alpha was found to enhance survival and neurite outgrowth of cultured neonatal rat dorsal root ganglion (DRG) neurons in a dose-dependent manner. This effect was observed with TGF alpha concentrations as low as 17.8 pM. By contrast, EGF at concentrations up to 83 nM was ineffective. Moreover, EGF did not antagonize the TGF alpha survival-promoting effect unless present in large excess (500-fold the concentration for which TGF alpha is effective); even in this case, only partial antagonism was achieved. Survival of neurons from nodose, trigeminal, and sympathetic ganglia was not increased by TGF alpha. Both a subpopulation of DRG neurons and of macrophages in the cultures bound iodinated TGF alpha. This binding was inhibited by excess unlabeled TGF alpha but not EGF. Our data are consistent with the possibilities that the actions of TGF alpha on DRG neurons occur indirectly via unidentified neurotrophic molecules other than NGF as well as directly on the neurons themselves. Thus, TGF alpha, in contrast to EGF, may act as a survival or maintenance factor for a subset of rat sensory neurons. Mediation of this neurotrophic effect appears to occur via a new form of TGF alpha receptor.
Assuntos
Fator de Crescimento Epidérmico/farmacologia , Gânglios Espinais/citologia , Neurônios Aferentes/fisiologia , Fator de Crescimento Transformador alfa/farmacologia , Animais , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Cromatografia Líquida de Alta Pressão , Relação Dose-Resposta a Droga , Fator de Crescimento Epidérmico/metabolismo , Receptores ErbB/metabolismo , Humanos , Cinética , Neurônios Aferentes/efeitos dos fármacos , Ratos , Fator de Crescimento Transformador alfa/isolamento & purificaçãoRESUMO
The human osteosarcoma cell line (OST-1-PF) can grow in protein-free Coon's modified Ham's F12 medium. Growth of the cells in protein-free medium was partially density-dependent and partially depressed by medium change. An extract and conditioned medium of OST-1-PF cells contained high mitogenic activity for BALB/c3T3 cells. The growth factor in the cells was purified and identified as a basic fibroblast growth factor (bFGF)--like factor on the basis of its elution profile on heparin-affinity chromatography and the result of immunoblotting. An unidentified factor in a conditioned medium eliciting most of the DNA synthesis-stimulating activity showed a weak affinity for heparin. Various additions, including serum and growth factors, stimulated the growth of OST-1-PF cells in protein-free medium. Of these factors, epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), acidic fibroblast growth factor (aFGF) and bFGF were the most potent mitogens. High-affinity receptors of EGF and FGF were found on the surface of these cells. These results indicate that autonomous growth of OST-1-PF cells in protein-free medium is mainly controlled by an intracellular mechanism.
Assuntos
Divisão Celular/fisiologia , Fator de Crescimento Epidérmico/fisiologia , Fatores de Crescimento de Fibroblastos/fisiologia , Fator de Crescimento Transformador alfa/fisiologia , Divisão Celular/efeitos dos fármacos , Meios de Cultura Livres de Soro , Fator de Crescimento Epidérmico/isolamento & purificação , Fatores de Crescimento de Fibroblastos/isolamento & purificação , Humanos , Osteossarcoma , Fator de Crescimento Transformador alfa/isolamento & purificação , Células Tumorais CultivadasAssuntos
Exotoxinas/genética , Imunotoxinas/genética , Fator de Crescimento Transformador alfa/genética , Clonagem Molecular , Exotoxinas/química , Exotoxinas/isolamento & purificação , Imunotoxinas/química , Imunotoxinas/isolamento & purificação , Conformação Proteica , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/isolamento & purificação , Fator de Crescimento Transformador alfa/química , Fator de Crescimento Transformador alfa/isolamento & purificaçãoRESUMO
A simple, micro-scale method was established for the characterization of growth factors at picogram levels using Phast system gel electrophoresis followed by monitoring the mitogenic activity by DNA synthesis in cell culture instead of staining methods. The separations and bioassays were carried out with a procedure involving Phast polyacrylamide gel electrophoresis or isoelectric focusing, gel slicing along the template, elution of growth factors through Transwell membranes and measurement of [3H]thymidine incorporation into DNA of normal rat kidney (NRK) fibroblasts. Transwell cell culture chamber inserts separated sliced gel pieces from culture cells and also permitted the direct elution of growth factors into the culture medium. The lower limit of sensitivity for human epidermal growth factor (hEGF) and transforming growth factor type alpha (TGF-alpha) were about 50 and 200 pg, respectively. At these concentrations, they were not detectable by the current most sensitive silver staining technique. Iodinated hEGF and TGF-alpha were also used to demonstrate the feasibility of determining the isoelectric point and molecular weight of peptides at picogram levels. This method is reliable, reproducible and can improve current methods for the characterization of growth factors.
Assuntos
DNA/biossíntese , Substâncias de Crescimento/isolamento & purificação , Animais , Linhagem Celular , Células Cultivadas , Eletroforese em Gel de Poliacrilamida , Fator de Crescimento Epidérmico/análise , Fator de Crescimento Epidérmico/isolamento & purificação , Fatores de Crescimento de Fibroblastos/análise , Fatores de Crescimento de Fibroblastos/isolamento & purificação , Focalização Isoelétrica , Microquímica , Mitógenos , Peso Molecular , Fator de Crescimento Derivado de Plaquetas/análise , Fator de Crescimento Derivado de Plaquetas/isolamento & purificação , Ratos , Fator de Crescimento Transformador alfa/análise , Fator de Crescimento Transformador alfa/isolamento & purificaçãoRESUMO
Transforming growth factor alpha (TGF-alpha) is generated by cleavage of a membrane-anchored precursor protein, proTGF-alpha. ProTGF-alpha is cleaved at a slow rate and accumulates on the cell surface, thereby mediating cell-cell adhesion and mitogenic stimulation. We show here that cleavage of membrane proTGF-alpha by an elastase-like enzyme constitutes an important regulatory step in the generation of soluble TGF-alpha. Cleavage is activated in response to serum factors and tumor-promoting phorbol esters, leading to depletion of cell surface proTGF-alpha, which disperses as soluble factor. Activation of proTGF-alpha cleavage is mediated by protein kinase C-dependent and -independent mechanisms. The results demonstrate the existence of mechanisms that control the switch of TGF-alpha from a juxtacrine to a paracrine growth factor.
Assuntos
Endopeptidases/metabolismo , Precursores de Proteínas/genética , Processamento de Proteína Pós-Traducional , Fator de Crescimento Transformador alfa/genética , Animais , Western Blotting , Adesão Celular , Linhagem Celular , Membrana Celular/enzimologia , Membrana Celular/fisiologia , Modelos Biológicos , Elastase Pancreática/metabolismo , Conformação Proteica , Acetato de Tetradecanoilforbol/farmacologia , Transfecção , Fator de Crescimento Transformador alfa/biossíntese , Fator de Crescimento Transformador alfa/isolamento & purificaçãoRESUMO
A wealth of recently derived information has strongly implicated the protooncogene erbB-2 (also termed HER-2 or neu) and its protein product as critically involved in human breast cancer as well as other important epithelial malignancies. Because of its substantial homology with the EGF receptor, erbB-2 has long been assumed to encode a growth factor receptor, although until recently definitive identification of ligand(s) has remained elusive. Both in a mutated form and when overexpressed in a non-mutated form, erbB-2 is capable of inducing malignant transformation of many target cells including immortalized breast epithelium. We have recently identified and purified a 30 kDa size growth factor secreted by some human breast cancer cells. The factor is related to transforming growth factor-alpha (TGF-alpha) in its ability to bind to the epidermal growth factor (EGF) receptor (though with about 10 fold lower apparent affinity), its ability to phosphorylate EGF receptor and its ability to induce cloning of normal rat kidney (NRK) fibroblasts. However, it is distinct from TGF-alpha as determined by peptide mapping and its ability to induce activation of erbB-2. TGF-alpha and EGF are incapable of directly inducing phosphorylation of erbB-2. However, in a variety of spontaneously occurring tumor cells as well as cell lines transfected with erbB-2 prepared in our laboratory, 30 kDa glycoprotein (gp30) is capable of inducing direct phosphorylation of erbB-2. The ability to induce phosphorylation of erbB-2 is not inhibited by an anti-EGF receptor blocking antibody. In cells that overexpress erbB-2, the gp30 low concentrations is stimulatory of both standard mitogenesis assays and in clonogenic assays. At higher concentrations, the ligand is growth inhibitory in both of these assays. Because of the ability of gp30 to compete for binding with antibodies directed against erbB-2 which inhibit growth, the gp30 ligand is capable of reversing antibody-induced inhibition of growth. In addition, the gp30 ligand can overcome inhibitory effects seen in cells which overexpress erbB-2 which are induced by extracellular domain fragments of the erbB-2 receptor, once again suggesting a specific pathway of action for the gp30 ligand mediated for interaction with erbB-2.(ABSTRACT TRUNCATED AT 400 WORDS)
Assuntos
Neoplasias da Mama/patologia , Substâncias de Crescimento/farmacologia , Proteínas Proto-Oncogênicas/fisiologia , Animais , Células CHO , Divisão Celular , Cricetinae , Receptores ErbB/análise , Receptores ErbB/metabolismo , Feminino , Humanos , Fosforilação , Proteínas Proto-Oncogênicas/análise , Proteínas Proto-Oncogênicas/genética , Receptor ErbB-2 , Fator de Crescimento Transformador alfa/isolamento & purificação , Fator de Crescimento Transformador alfa/fisiologiaAssuntos
Baculoviridae/genética , Fator de Crescimento Epidérmico/isolamento & purificação , Receptores ErbB/genética , Vetores Genéticos , Transfecção , Animais , Linhagem Celular , Técnicas de Cultura/métodos , Fator de Crescimento Epidérmico/metabolismo , Receptores ErbB/isolamento & purificação , Receptores ErbB/metabolismo , Humanos , Insetos , Cinética , Camundongos , Camundongos Endogâmicos , Peso Molecular , Fosforilação , Plasmídeos , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Fator de Crescimento Transformador alfa/isolamento & purificação , Fator de Crescimento Transformador alfa/metabolismoRESUMO
Previously we have developed a microassay for anchorage independent growth (AIG) of fibroblasts in soft agar, which can detect very small quantities of transforming growth factors (TGFs). Using this assay, we have shown that small pieces of dissected chick embryo tissue will stimulate AIG of both NR6 and NRK 49f cells, and that this property can be used to map production of growth factors with transforming activity in individual early embryos. We now show that this activity can be transferred to conditioned medium (CM) prepared using chick embryo tissue. Using two cell lines with differential responsiveness to TGFs, and by coincubating normal and heat-treated CM with trypsin, Con-A and neutralising antibodies, we show that CM contains at least two different growth factors with transforming activity. One of these is heat-stable, and stimulates colony formation in NRK 49f cells in the presence of EGF, but not in its absence. This activity corresponds to a TGF beta-like molecule. The other component is a heat-labile glycoprotein, which has TGF alpha-like properties, but does not appear to behave like known TGFs with these properties. It therefore appears to be a novel growth factor. Both activities are present from the intermediate primitive streak stage of development.
Assuntos
Fator de Crescimento Transformador alfa/isolamento & purificação , Animais , Bioensaio/métodos , Linhagem Celular , Embrião de Galinha , Temperatura AltaRESUMO
Multiple transforming growth factors (TGFs) capable of conferring the neoplastic phenotype on NRK-49F cells without the addition of any other exogenous growth factor in the soft agar assay, were purified from two human solid malignant neoplasms: a squamous lung carcinoma and a pectoral rhabdomyosarcoma. In both tumors, low-molecular-weight transforming activities (4000-6000) that were not potentiated by epidermal growth factor (EGF), competed for binding to the EGF receptor, possessed mitogenic activity on NRK fibroblasts arrested in serum-deprived medium, and did not show inhibitory effects on DNA synthesis induced by EGF and insulin in NRK cells. Other TGFs with molecular weights 9000 to 48,000, were also found in the malignant tissues examined; these TGFs, were not potentiated by EGF, did not compete for binding to the EGF receptor, were not mitogenic for NRK cells, and acted as potent inhibitors of DNA synthesis induced by EGF and insulin in NRK cells. These results demonstrate that growth-promoting activities, and modulating agents that can act as either enhancers or inhibitors of cell proliferation, are present in neoplastic tissues of different embryologic origin and histologic type.